<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04120870</url>
  </required_header>
  <id_info>
    <org_study_id>MED-OBS-19-294</org_study_id>
    <nct_id>NCT04120870</nct_id>
  </id_info>
  <brief_title>Comparison of Ketamine and Etomidate During Rapid Sequence Intubation in Trauma Patients</brief_title>
  <official_title>Comparison of Effects on Hemodynamics Between Ketamine and Etomidate During Rapid Sequence Intubation in Trauma Patients With High Shock Index</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ajou University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Unimedics (http://unimedics.co.kr)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Ajou University School of Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In trauma patients with high shock index, the investigators compare the effects on
      hemodynamics between ketamine and etomidate.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In trauma patients, rapid sequence intubation is recommended. The drug of choice, however,
      has been debated. One cohort comparative study showed ketamine had benefit in hemodynamics
      compared to etomidate in trauma patients. One observational study showed in high shock index
      patients, ketamine showed maintain systolic blood pressure. And other retrospective showed
      less clinical hypotension was less in ketamine. However there is no randomized controlled
      study comparing ketamine and etomidate in trauma patients. The purpose of this study is
      comparing the effects of hemodynamics between ketamine and etomidate in high shock index
      trauma patients.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2019</start_date>
  <completion_date type="Anticipated">October 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>ketamine group: ketamine 2 mg/kg iv as induction agent etomidate group: etomidate 0.2 mg/kg iv as induction agent</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>open label</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Systolic blood pressure difference compared with baseline after 10 minutes</measure>
    <time_frame>13 minutes</time_frame>
    <description>Systolic blood pressure 10 minutes after induction agent injection - baseline systolic blood pressure mmHg Positive or zero value means good result. Negative value means poor result.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intubating condition</measure>
    <time_frame>5 minutes</time_frame>
    <description>Intubator judge intubating condition Laryngoscopy: easy / fair / difficult (difficult is the worst result) Vocal cords position: abducted / moving / closed (closed is the worst result) Reaction to insertion of the tracheal tube and cuff inflation : none / slight / vigorous (none is the worst result)
If one of category checked the worst score, it considered :clinically unacceptable&quot;.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of hypotension</measure>
    <time_frame>25 minutes</time_frame>
    <description>If any of these are checked, define as hypotension (from injection of induction agent to 20 minutes after)
systolic pressure &lt; 90 mmHg
systolic pressure decrease &gt; 40% compared to baseline
Initiation of vasopressor
Vasopressor dose increase &gt; 30% of initial vaopressor dose
Fluid or blood loading
Patient numbers (%)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of hypertension</measure>
    <time_frame>25 miinutes</time_frame>
    <description>From injection of induction agent to 20 minutes after, systolic pressure &gt; 160 mmHg defined as hypertension
Patients numbers (%)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Trauma</condition>
  <condition>Shock, Traumatic</condition>
  <arm_group>
    <arm_group_label>Etomidate</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The induction agent of rapid sequence intubation is etomidate. 0.2 mg/kg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ketamine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The induction agent of rapid sequence intubation is ketamine. 2 mg/kg</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Etomidate Injection 0.2 mg/kg</intervention_name>
    <description>The induction agent of rapid sequence intubation is etomidate. 0.2 mg/kg</description>
    <arm_group_label>Etomidate</arm_group_label>
    <other_name>Etomidate</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketamine injection 2 mg/kg</intervention_name>
    <description>The induction agent of rapid sequence intubation is ketamine. 2 mg/kg</description>
    <arm_group_label>Ketamine</arm_group_label>
    <other_name>Ketamine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age 19~70

          -  Shock index â‰¥ 0.9

          -  Patients who need intubation regarding to Ajou trauma center protocol

        Exclusion Criteria:

          -  during CPR

          -  CPR before hospital arrival

          -  Severe head trauma

          -  Steroid intake history
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>In Kyong Yi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ajou University School of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>In Kyong Yi, MD</last_name>
    <phone>+82-31-219-7522</phone>
    <email>lyrin01@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yo Heo, MD</last_name>
    <phone>+82-31-219-7492</phone>
    <email>107696@aumc.ac.kr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Ajou university school of medicine</name>
      <address>
        <city>Suwon</city>
        <state>Gyeonggi-do</state>
        <zip>16499</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>In Kyong Yi, MD</last_name>
      <phone>+82-10-3012-6972</phone>
      <email>lyrin01@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Yoon Jung Chae, MD</last_name>
      <phone>+82-31-219-5689</phone>
    </contact_backup>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>September 26, 2019</study_first_submitted>
  <study_first_submitted_qc>October 8, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 9, 2019</study_first_posted>
  <last_update_submitted>October 16, 2019</last_update_submitted>
  <last_update_submitted_qc>October 16, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 18, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ajou University School of Medicine</investigator_affiliation>
    <investigator_full_name>In-kyong Yi</investigator_full_name>
    <investigator_title>Clinical assistant professor</investigator_title>
  </responsible_party>
  <keyword>etomidate</keyword>
  <keyword>ketamine</keyword>
  <keyword>rapid sequence intubation</keyword>
  <keyword>trauma</keyword>
  <keyword>hemodynamics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Shock, Traumatic</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ketamine</mesh_term>
    <mesh_term>Etomidate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>If there is a reasonable request, we can share the data personally.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

